The Small Business Innovation Research (SBIR) program is offering this grant to support small business concerns (SBCs) in developing innovative technologies. This grant is specifically for funding research aimed at creating new therapeutics and monitoring technologies for Type 1 Diabetes (T1D). The primary purpose is to advance progress towards integrated, long-term glucose-regulated insulin/pancreatic hormone delivery systems, commonly known as an artificial pancreas. This initiative seeks to foster groundbreaking solutions that can significantly improve the management and treatment of T1D, ultimately enhancing patient care and quality of life through advanced medical device development.
Opportunity ID: 248816
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-13-028 |
| Funding Opportunity Title: | Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D): Towards an Artificial Pancreas (SBIR) (R43/R44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 04, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Mar 14, 2014 |
| Current Closing Date for Applications: | Mar 14, 2014 |
| Archive Date: | Apr 14, 2014 |
| Estimated Total Program Funding: | $2,500,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward integrated long term glucose regulated insulin/pancreatic hormones delivery systems (artificial pancreas). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-028.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.847 | ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00190634 | Feb 14, 2014 | Mar 14, 2014 | View |
Package 1
Mandatory forms
248816 RR_SF424_1_2-1.2.pdf
248816 PerformanceSite_1_4-1.4.pdf
248816 RR_OtherProjectInfo_1_3-1.3.pdf
248816 RR_KeyPersonExpanded_1_2-1.2.pdf
248816 RR_Budget-1.1.pdf
248816 PHS398_CoverPageSupplement_1_4-1.4.pdf
248816 PHS398_ResearchPlan_1_3-1.3.pdf
248816 PHS398_Checklist_1_3-1.3.pdf
248816 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
248816 RR_SubawardBudget30-1.2.pdf
248816 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
